The ability to probe the smallest building blocks of matter has long fascinated scientists, fueling advancements in medicine, ...

Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity ...

Researchers have developed a new material that could help to remove unwanted pollutants — including leftover medicines and ...

Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on ...

Insilico Medicine (“Insilico”) announces that the team, with the support of its generative chemistry engine, has developed a ...

drug in hand : diabetes medication hologram drug chemical structure in futuristic technology for patient diabetes medication hologram drug chemical structure drug in hand : diabetes medication ...

On the 5th, LG AI Research signed a joint research agreement at the Global Lounge of LG Science Park in Magok, Gangseo-gu, ...

"Changes in the industry and business structure have reduced the potential for synergies," Mitsubishi Chemical said in a statement. "Large-scale investment is essential to strengthen Mitsubishi ...

Tokyo, Feb. 7 (Jiji Press)--Mitsubishi Chemical Group Corp. said Friday that it will sell subsidiary Mitsubishi Tanabe Pharma Corp. to U.S. investment firm Bain Capital LP. for about 510 billion yen.

The company will thus separate its pharmaceutical business, which requires expenditure to expand new drug candidates, and will then focus on revitalizing its chemical businesses.

A team of US researchers has found that drugs being sold as fentanyl contain high amounts of an industrial chemical which could be dangerous for humans. The new chemical called BTMPS emerged in the ...